CD8A and leukemia: For example, CTL019, which is the most widely used CAR in CD19+ leukemia and lymphoma treatment, has a CD8α hinge [46, 47], while CD19RCD28 CAR uses a modified IgG4 hinge and Fc region [48], and also has a hinge-deleted version [19].